ESC Premium Access

Pulmonary hypertension due to left heart disease should be treated with drugs approved for idiopathic pulmonary arterial hypertension - CON

Congress Session

About the speaker

Doctor Javier Bermejo Thomas

University Hospital Gregorio Maranon, Madrid (Spain)
4 presentations
0 follower

5 more presentations in this session

Lifelong anticoagulation is the best option after unprovoked venous thromboembolism - PRO

Speaker: Professor L. Mazzolai (Lausanne, CH)

Thumbnail

Lifelong anticoagulation is the best option after unprovoked venous thromboembolism - CON

Speaker: Professor N. Meneveau (Besancon, FR)

Thumbnail

Lifelong anticoagulation is the best option after unprovoked venous thromboembolism - Discussion

Thumbnail

Pulmonary hypertension due to left heart disease should be treated with drugs approved for idiopathic pulmonary arterial hypertension - PRO

Speaker: Professor S. Rosenkranz (Cologne, DE)

Thumbnail

Pulmonary hypertension due to left heart disease should be treated with drugs approved for idiopathic pulmonary arterial hypertension - Discussion

Thumbnail

Access the full session

Controversies in the management of pulmonary hypertension and venous thromboembolism

Speakers: Doctor J. Bermejo Thomas, Professor L. Mazzolai, Professor N. Meneveau, Professor S. Rosenkranz
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk